SIGN UP

Richard Gonzalez, AbbVie CEO (Pablo Martinez Monsivais/AP Images)

February 20, 2024 09:26 AM EST

AbbVie CEO Richard Gonzalez to retire July 1 with Humira transition underway

Kyle LaHucik

Senior Reporter

AbbVie CEO Richard Gonzalez will hand the CEO post to president and COO Robert Michael on July 1 as the Chicago-area Big Pharma progresses through …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

sponsored

Are programs with compounded GLP-1s safe for your population?